COSTA MESA, Calif., March 31 /PRNewswire-FirstCall/ -- CNS Response, Inc. (OTC Bulletin Board: CNSO) today announced the implementation of its agreement to roll out referenced-EEG(R) (rEEG(R)) availability with an undisclosed, national managed behavioral health organization (MBHO). This agreement enables psychiatrists under the management of the MBHO to utilize CNS Response's rEEG medication guidance to treat their most therapy-challenged patients suffering any of the behavioral disorders with the exception of schizophrenia. MBHO's contract with managed care companies and employers to manage the behavioral health benefits of their health plans toward appropriateness, efficacy, and efficiency.
George Carpenter, CNSO President specified, "Although we worked out the parameters of the contract earlier last year, this month we completed agreement on all key elements of our first rEEG implementation with a major MBHO. Those elements included patient qualifications, CNSO laboratory certification, rEEG reimbursement codes and rates, behavioral network training and network support services.
"Importantly, this is not a 'pilot program.' Our client concluded that, given the level of unmet clinical need among treatment-resistant populations, implementation was in the best interest of its corporate clients and their employees."
Daniel Hoffman, MD, Chief Medical Officer for CNS Response, explained, "It is not just that rEEG has been successful in guiding doctors in the majority of hard-to-treat cases. It is also the fact that, until now, physicians have had little evidence to support other approaches. This was demonstrated by a very large National Institute of Mental Health study, STAR*D, published last year. I think the combination of these two points is responsible for the attention CNS Response is now receiving."
Len Brandt, Chairman and CEO of CNS Response, commented, "We are
enthused to begin implementing our first payer contract. We expect
|SOURCE CNS Response, Inc.|
Copyright©2008 PR Newswire.
All rights reserved